High materiality7/10
ImmunityBio price target raised to $16 from $12 at Piper Sandler
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raises ImmunityBio (IBRX) price target to $16 from $12; current price around $9.91.
Key facts
- 01
Target: $16
- 02
Posted price: $9.91
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.